|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Interventional Pulmonology (Dr. Wahidi), Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC; the Department of Pulmonary and Critical Care Medicine (Dr. Herth), Thoraxklinik Heidelberg, Heidelberg, Germany; and the Department of Interventional Pulmonology (Dr. Ernst), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Correspondence to: Armin Ernst, MD, FCCP, Chief, Interventional Pulmonology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA 02215; e-mail: aernst{at}bidmc.harvard.edu
Abstract
Interventional pulmonology (IP) provides comprehensive care to patients with structural airway disorders and pleural diseases. A growing armamentarium of diagnostic and therapeutic tools has expanded the interventional pulmonologists ability to care for pulmonary patients with complex abnormalities, often in concert and close collaboration with physicians in other specialties, such as thoracic surgery. Innovative technologies promise to have an impact on diseases and clinical entities not traditionally treated by invasive pulmonary interventions, such as asthma, COPD, and the solitary pulmonary nodule. Training, credentialing, reimbursement, and scientific validation remain key necessities for the continued growth of IP, and require a concerted effort by chest physicians and their professional organizations.
Key Words: airways bronchoscopy interventional pulmonology pleural disease procedures
This article has been cited by other articles:
![]() |
A. J. Reddy, J. A. Govert, T. A. Sporn, and M. M. Wahidi Broncholith Removal Using Cryotherapy During Flexible Bronchoscopy: A Case Report Chest, November 1, 2007; 132(5): 1661 - 1663. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |